Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle.
Adaptive activation of thyroid hormone and energy expenditure.
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Racial disparities in kidney transplant waitlist appearance in Chicago: Is it race or place?
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
.
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
. Leuk Lymphoma. 2018 01; 59(1):256-258.
View in:
PubMed
subject areas
Antiviral Agents
Eukaryotic Initiation Factor-4E
Humans
Lymphoma
Remission Induction
Respiratory Syncytial Virus Infections
Respiratory Syncytial Viruses
Retrospective Studies
Ribavirin
authors with profiles
Koen Van Besien